Reselute develops solutions for the treatment of orthopaedic implant related infections.
Reselute has raised $1.0M in total funding. The most recent round was Convertible Note. The last funding was announced in July 2026.
Reselute's investors include National Science Foundation, One North Carolina Small Business Program.
Reselute is headquartered in Durham, United States.
Reselute develops solutions for the treatment of orthopaedic implant related infections.
Reselute is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Reselute — Funding & Investors." VCBacked, July 22, 2026, https://www.vcbacked.co/company/reselute. Accessed September 29, 2026.
VCBacked. (2026). Reselute — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/reselute
{{cite web |title=Reselute — Funding & Investors |url=https://www.vcbacked.co/company/reselute |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated